objective objective compare regime term disease free$$survival breast patient regime taxane base anthracycline base cmf cyclophosphamide methotrexate fluorouracil historical$$cohort patient confirm metastatic follow patient undergo modify radical mastectomy surgery receive adjuvant medical center tehran iran extend log logistic$$regression model compare regime age patient median follow month probability survival analysis type cmf taxane anthracycline taxane grade iii tumor size nodal involvement affect conclusion current reveal efficacy taxane base term cmf taxane base prolonged$$anthracycline base finally tumor size histological$$grade involve lymph lengthen crucial$$highlight public education screening program detect tumor
